HEALTHeUNIVERSE (OTCPK:HLUN) - Stock Price, News & Analysis

HLUN Stock Overview

HLUN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

High level of non-cash earnings

Does not have a meaningful market cap ($117)

Shares are highly illiquid

HEALTHeUNIVERSE, Inc. Competitors

DermTech

OTCPK:DMTK.Q

US$35.0

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

Genocea Biosciences

OTCPK:GNCA.Q

US$5.9k

RVL Pharmaceuticals

OTCPK:RVLP.Q

US$111.0

Price History & Performance

Summary of all time highs, changes and price drops for HEALTHeUNIVERSE
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000016
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	HLUN	US Biotechs	US Market
7D	0%	4.3%	1.6%
1Y	n/a	18.8%	32.3%

Return vs Industry: Insufficient data to determine how HLUN performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how HLUN performed against the US Market.

Price Volatility

Is HLUN's price volatile compared to industry and market?
HLUN volatility
HLUN Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: HLUN's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine HLUN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Vipul Dev	n/a

Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. It also provides consulting services to various businesses in the areas of marketing, business organization, and raising capital for business ventures.

HEALTHeUNIVERSE, Inc. Fundamentals Summary

How do HEALTHeUNIVERSE's earnings and revenue compare to its market cap?
HLUN fundamental statistics
Market cap	US$117.00
Earnings (TTM)	US$42.80k
Revenue (TTM)	US$481.79k

0.0x

P/E Ratio

0.0x

P/S Ratio

Is HLUN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLUN income statement (TTM)
Revenue	US$481.79k
Cost of Revenue	US$18.63k
Gross Profit	US$463.15k
Other Expenses	US$420.35k
Earnings	US$42.80k

Last Reported Earnings

Sep 30, 2006

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did HLUN perform over the long term?

See historical performance and comparison